An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer
Multi-modal image analysis using deep learning (DL) lays the foundation for neoadjuvant treatment (NAT) response monitoring. However, existing methods prioritize extracting multi-modal features to enhance predictive performance, with limited consideration on real-world clinical applicability, particularly in longitudinal NAT scenarios with multi-modal data. Here, we propose the Multi-modal Response Prediction (MRP) system, designed to mimic real-world physician assessments of NAT responses in breast cancer. To enhance feasibility, MRP integrates cross-modal knowledge mining and temporal information embedding strategy to handle missing modalities and remain less affected by different NAT settings. We validated MRP through multi-center studies and multinational reader studies. MRP exhibited comparable robustness to breast radiologists, outperforming humans in predicting pathological complete response in the Pre-NAT phase (ΔAUROC 14% and 10% on in-house and external datasets, respectively). Furthermore, we assessed MRP's clinical utility impact on treatment decision-making. MRP may have profound implications for enrolment into NAT trials and determining surgery extensiveness.
Authors
- Luyi Han (ORCID: https://orcid.org/0000-0003-4046-2763)
- Muzhen He (ORCID: https://orcid.org/0000-0001-5588-725X)
- Yuan Gao (ORCID: https://orcid.org/0000-0001-6326-129X)
- Hugo M. Horlings (ORCID: https://orcid.org/0000-0003-4782-8828)
- Valentina Laurita Longo (ORCID: https://orcid.org/0000-0003-4071-9936)
- Anna D’Angelo (ORCID: https://orcid.org/0000-0001-5970-1010)
- Xin Wang (ORCID: https://orcid.org/0000-0001-9619-7503)
- Sofía Ventura‐Díaz (ORCID: https://orcid.org/0000-0002-6541-7910)
- Marleen Kok (ORCID: https://orcid.org/0000-0001-9043-9815)
- Ritse M. Mann (ORCID: https://orcid.org/0000-0001-8111-1930)
- Frederieke van Duijnhoven (ORCID: https://orcid.org/0000-0003-3694-4049)
- Xiao‐Mei Li (ORCID: https://orcid.org/0000-0002-1769-127X)
- Tianyu Zhang (ORCID: https://orcid.org/0000-0001-9891-6874)
- Hong-Yu Zhou (ORCID: https://orcid.org/0000-0002-1256-7050)
- Tao Tan (ORCID: https://orcid.org/0000-0001-5403-0887)
- Zeyan Xu (ORCID: https://orcid.org/0000-0003-1384-3536)
- Regina G. H. Beets‐Tan (ORCID: https://orcid.org/0000-0002-8533-5090)
- Jonas Teuwen
- Zaiyi Liu
- Alva B. Weir
Institutions
- Fujian Medical University (CN)
- Harvard University (US)
- Radboud University Nijmegen (NL)
- Jinan University (CN)
- Kunming Medical University (CN)
- Maastricht University Medical Centre (NL)
- Cork University Hospital (IE)
- Agostino Gemelli University Polyclinic (IT)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Key Laboratory of Guangdong Province (CN)
- Fujian Provincial Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Guangdong Provincial People's Hospital (CN)
- Macao Polytechnic University (MO)
- Southern Medical University (CN)
- St. Joseph’s Healthcare Hamilton (CA)
- Fuzhou University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1038/s41467-024-53450-8
- Citations
- 53
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 15.11
Funders
- China Scholarship Council